GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Enterprise Value

Entheon Biomedical (XCNQ:ENBI) Enterprise Value : C$1.08 Mil (As of Jun. 05, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Entheon Biomedical's Enterprise Value is C$1.08 Mil. Entheon Biomedical's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.28 Mil. Therefore, Entheon Biomedical's EV-to-EBIT ratio for today is -3.84.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Entheon Biomedical's Enterprise Value is C$1.08 Mil. Entheon Biomedical's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.28 Mil. Therefore, Entheon Biomedical's EV-to-EBITDA ratio for today is -3.84.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Entheon Biomedical's Enterprise Value is C$1.08 Mil. Entheon Biomedical's Revenue for the trailing twelve months (TTM) ended in Feb. 2024 was C$0.13 Mil. Therefore, Entheon Biomedical's EV-to-Revenue ratio for today is 8.30.


Entheon Biomedical Enterprise Value Historical Data

The historical data trend for Entheon Biomedical's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Enterprise Value Chart

Entheon Biomedical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Nov21 Nov22 Nov23
Enterprise Value
Get a 7-Day Free Trial 1.04 0.41 29.86 1.09 0.25

Entheon Biomedical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.28 1.58 1.10 0.25 0.34

Competitive Comparison of Entheon Biomedical's Enterprise Value

For the Biotechnology subindustry, Entheon Biomedical's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Entheon Biomedical's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entheon Biomedical's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Entheon Biomedical's Enterprise Value falls into.



Entheon Biomedical Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Entheon Biomedical's Enterprise Value for the fiscal year that ended in Nov. 2023 is calculated as

Entheon Biomedical's Enterprise Value for the quarter that ended in Feb. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Entheon Biomedical  (XCNQ:ENBI) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Entheon Biomedical's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1.079/-0.281
=-3.84

Entheon Biomedical's current Enterprise Value is C$1.08 Mil.
Entheon Biomedical's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.28 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Entheon Biomedical's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=1.079/-0.281
=-3.84

Entheon Biomedical's current Enterprise Value is C$1.08 Mil.
Entheon Biomedical's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.28 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Entheon Biomedical's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1.079/0.13
=8.30

Entheon Biomedical's current Enterprise Value is C$1.08 Mil.
Entheon Biomedical's Revenue for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Entheon Biomedical Enterprise Value Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Entheon Biomedical (XCNQ:ENBI) Business Description

Traded in Other Exchanges
Address
999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.
Executives
Brian Jahns Senior Officer

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines